FY2025 · ended Dec 31, 2025 · Revenue $2.55M, -0.2% YoY · Filed Apr 15, 2026
ENvue Medical, Inc. (FEED) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.6 million and a net loss of $18.2 million. Free cash flow was -$9.4 million. As of Jun 30, 2026 it held $1.1 million in cash and investments and $230,000 in total debt.
Revenue (TTM)
$1.93M
-17.7% vs year-ago TTM
Net income (TTM)
$-21.06M
-154.6% vs year-ago TTM
Operating cash flow (TTM)
$-11.65M
-90.7% vs year-ago TTM
Free cash flow (TTM)
$-11.74M
-91.9% vs year-ago TTM
EPS (TTM)
$-17.39
+46.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
3.70M
+387.4% vs prior year
Net cash
$854,000
as of Jun 30, 2026
Operating margin
-1362.7%
FY 2026
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- FEED (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Tyler, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1326706
- Former names
- NanoVibronix, Inc. (until Dec 12, 2025); Nano Vibronix, Inc. (until Mar 25, 2014); Nano Vibronix Inc (until May 5, 2005)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.6M | $2.6M | $2.3M | $752,000 | $1.7M |
| Operating income | -$22.9M | -$3.6M | -$3.4M | -$5.0M | -$5.7M |
| Net income | -$18.2M | -$3.7M | -$3.7M | -$5.4M | -$14.3M |
| Diluted EPS | -$26.69 | -$137.30 | -$23.32 | — | — |
| Operating cash flow | -$9.4M | -$2.5M | -$3.6M | -$7.0M | -$4.4M |
| Free cash flow | -$9.4M | -$2.5M | -$3.6M | -$7.0M | -$4.4M |
| Total assets | $41.1M | $3.6M | $6.7M | $5.9M | $8.6M |
| Total liabilities | $7.6M | $3.0M | $2.7M | $2.6M | $2.3M |
| Stockholders' equity | $33.5M | $627,000 | $4.0M | $3.2M | $6.3M |
| Cash and investments | $4.2M | — | — | — | $7.7M |
| Total debt | $117,000 | $115,000 | $5.0M | $73,000 | $49,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, New debt, Bylaw or fiscal year change
|
Oct 14, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Aug 31, 2026 | Aug 28, 2026 |
| 10-Q | Quarterly report | Aug 17, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2026 | Jul 14, 2026 |
All 551 ENvue Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.